VigiLanz Releases New Survey That Reveals Hospitals’ Top Safety Challenges and COVID-19’s Impact on Safety Priorities

For the first time in three years, hospital leaders say improving safety is a higher strategic priority than improving efficiency and reducing costs

MINNEAPOLIS, April 28, 2021 — VigiLanz, a clinical surveillance company, today released findings from their third annual hospital patient safety survey. The independent survey of 100 hospital and health system leaders, conducted in March 2021 by Sage Growth Partners, reveals significant year-over-year changes in how hospital leaders are prioritizing and approaching patient and staff safety.

For the first time in three years, hospital leaders said patient safety is a higher strategic priority than improving efficiency and reducing costs. Hospital leaders also said they are placing more emphasis on decreasing hospital-acquired infections (HAIs) and improving staff safety in 2021 than in years prior.

The full results are included in VigiLanz’s new Hospital Patient Safety Report 2021. Key findings include:

For the first time since 2019, improving patient safety is a higher strategic priority among hospital leaders than increasing efficiency and reducing costs.

  • Hospital leaders were more likely to select improving patient safety as a top strategic priority than increasing efficiency and reducing costs (57% said improving safety was in their top three strategic priorities, while only 50% said improving efficiency and reducing costs was). Hospital leaders were most likely to select delivering high quality care as one of their top three strategic priorities (77%).
  • The percentage of hospitals leaders who selected improving patient safety as a top three strategic priority has steadily increased over the past three years (40% in 2019, 50% in 2020, and 57% in 2021).
  • The percentage of hospital leaders who selected increasing efficiency and reducing costs has steadily decreased over the past three years (60% in 2019, 53% in 2020, and 50% in 2021).

Note: Other strategic priorities survey respondents could select included driving patient engagement (39%), focusing on ethics and compliance (5%), focusing on revenue improvement (16%), gaining market share (19%), investing in technologies (3%), managing population health (10%), and participating in alternative payment models (2%).

Hospital-acquired infections (HAIs) are hospitals’ top safety challenge; however, hospital leaders are growing more confident in their infection prevention capabilities.

  • Hospital leaders were most likely to select HAIs as their top safety challenge (30%), followed by medication errors (19%), and falls (16%).
  • Significantly more hospital leaders said they are extremely confident that their hospital can respond to an infectious disease of viral outbreak as soon as a patient presents symptoms in 2021 than in 2020 (44% vs. 27%).
  • Ninety-five percent said the pandemic has made infection prevention a higher hospital priority.

Protecting staff is a new top safety improvement priority for hospitals, and the pandemic is a key driver.

  • Hospital leaders were most likely to select improving staff safety as their top safety improvement priority (39%), followed by reducing HAIs and HACs (23%), reducing falls and other accidents (15%), and reducing medication errors (10%).
  • Ninety-one percent said the pandemic made improving staff safety a higher priority, and 41% said their hospital lacked adequate PPE during the pandemic.

The pandemic led to an increase in antibiotic use and medication errors within hospitals.

  • Forty-nine percent of hospital leaders said the pandemic led to an increase antibiotic prescriptions.
  • Twenty-one percent said the pandemic led to an increase in medication errors.

More hospital leaders are turning to clinical surveillance technologies to address safety challenges.

  • Ninety-five percent of hospital leaders said clinical surveillance either probably or definitely improves patient safety.
  • Most said clinical surveillance tools help identify potential infections and outbreaks (85%), safety events (85%), medication errors (70%), and antibiotic overuse (70%).
  • Sixty-nine percent said they already use the technology or plan to implement it in the next two years.

“Hospitals are facing new and unexpected challenges, and this is transforming how hospital leaders think about safety and how they prioritize it,” said VigiLanz Chairman and CEO David Goldsteen, MD. “For the first time in three years, hospital leaders are saying that improving patient safety is a higher priority than increasing efficiency and reducing costs. The pandemic revealed safety gaps and vulnerabilities, and the survey findings show that hospitals are moving quickly to address these problems with new technologies and initiatives that will have a long-lasting, positive impact.”

VigiLanz was recently recognized as Best in KLAS for Infection Control and Monitoring and Pharmacy Surveillance in the “2021 Best in KLAS: Software and Services” report. Over the past four years, VigiLanz has earned 10 KLAS awards for its solutions.

 

Methodology

VigiLanz commissioned Sage Growth Partners, a healthcare consultancy, to conduct the independent survey of 100 hospital and health system leaders in March 2021. Respondents included pharmacy executives (28%), infection prevention executives (22%), chief executive officers (13%), chief medical officers (12%), chief nursing officers (9%), and quality executives (7%). For more demographics and methodology, download the full report.

 


About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance solutions. The firm is focused on aggregating disparate EMR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care.

 

Media Contact

Boh Hatter
(410) 534.1161
bhatter@sage-growth.com

VigiLanz Launches Intelligent Event Reporting Suite, Expands #1 Rated Clinical Surveillance Platform Impacting Patient Safety, Risk, Compliance, and Patient Relations

Automated event detection, expedited documentation, and enterprise-wide visibility help hospitals and health systems improve safety and reduce risks

MINNEAPOLIS, April 7, 2021VigiLanz, a clinical surveillance company, today announced the launch of three new event reporting solutions built on VigiLanz’s award-winning enterprise software platform. The new solutions, VigiLanz Risk and Claims, VigiLanz Compliance, and VigiLanz Patient Relations, complement VigiLanz’s existing Dynamic Safety Surveillance product to expand the platform’s benefits and improve hospitals’ bottom line by enabling them to quickly capture, monitor, and act on information, enhancing patient safety and reducing organizational risk.

Recently recognized as Best in KLAS for Infection Control and Monitoring and Pharmacy Surveillance, VigiLanz applied its more than 20 years of complex, clinical data experience to create and integrate the new solutions, which help hospitals harness their own data to make safety improvements and reduce risks. Key capabilities include automated event capture; expedited documentation through form autopopulation; and enhanced visibility into events and improvement opportunities through deep integration that results in data-rich enterprise dashboards.

“In order for hospitals to foster an overarching culture of safety, risk mitigation must be addressed for patients, visitors, and employees,” said Stacy Pur, VigiLanz’s VP of Product Development. “These solutions create a canopy of protection for hospitals and their patients. This allows a system-wide approach to reducing risks and improving patient satisfaction, while also saving time. Enhanced visibility, highly targeted notifications, expedited documentation, and easy escalation processes are just a few of the benefits hospitals will experience.”

Want more information on our event reporting solutions?

About the solutions:

VigiLanz Dynamic Safety Surveillance
VigiLanz optimizes safety event reporting through real-time alerts, auto-detection of events, comprehensive management and investigation tools, automated escalation, and a full library of analytics and reporting capabilities.

VigiLanz Risk and Claims
VigiLanz streamlines workflows throughout the entire lifecycle of claims and litigation events and identifies risk-reduction and damage-control opportunities. Key benefits include the ability to easily enter, manage, and escalate claims and budgets; analyze department-specific and enterprise-wide data; and continuously improve by mitigating risks and preventing future incidents.

VigiLanz Compliance
VigiLanz helps prevent, detect, and resolve illegal or unethical conduct and promotes a culture of ethical practice. Features include automated violation notifications, comprehensive management and escalation tools, and department-specific and enterprise-wide reports and analytics.

VigiLanz Patient Relations
VigiLanz streamlines the management of patient and visitor feedback, identifies patient satisfaction improvement and service recovery opportunities, and optimizes value-based reimbursement through simplified workflows, escalation tools, and enterprise-wide reporting.

“The event reporting solutions could not have been launched at a better time, as hospitals are working tirelessly to improve care during the COVID-19 pandemic and implement lessons learned from it,” said David Goldsteen, VigiLanz’s CEO. “We’re proud of our ability to continually raise the bar for clinical surveillance, and put it into the hands of more healthcare workers. We’re supporting more efficient workflows and maximizing their resources, while also helping them improve care and reduce risks.”

Learn more about the new and expanded solutions at VigiLanzcorp.com.

VigiLanz earned Best in KLAS in the “2021 Best in KLAS: Software and Services” report, released February 2, 2021. Over the past four years, VigiLanz has earned 10 KLAS awards for its solutions.

About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care.

VigiLanz Ranked No. 1 by KLAS Research for Infection Control and Monitoring and Pharmacy Surveillance for Fourth Straight Year

The clinical surveillance company most trusted by hospitals is recognized as Best in KLAS, totaling 10 KLAS awards over 4 consecutive years

MINNEAPOLIS – Feb. 2, 2021 – VigiLanz, a clinical surveillance company, today announced that it has earned 2021 Best in KLAS designations from KLAS Research for Infection Control and Monitoring and Pharmacy Surveillance. This is the fourth year VigiLanz has been recognized by KLAS as a leader across both areas, and brings its total count of KLAS awards to 10. VigiLanz was also recognized in previous years in the Antimicrobial Stewardship category, which KLAS folded into Pharmacy Surveillance this year.

VigiLanz products earned Best in KLAS across two segments in the “2021 Best in KLAS: Software and Services” report, released on February 2:

Infection Control and Monitoring

Earning a score of 93.7, VigiLanz’s Dynamic Infection Control Monitor is a seamless, real-time automated monitoring system that works with an organization’s EHR. Its exception-based alert system puts all patient records under continuous surveillance to alert decision makers in real time of potential infections, MDROs, isolation candidates, organism clusters, conditions of concern, and reportable infections. The surveillance is based on a sophisticated set of customizable rule engines.

“VigiLanz has been really good through the COVID-19 crisis because every time we need a new test, I just email the vendor, and they add it to the product. The vendor’s help has been a blessing.”

  • Physician, August 2020, klasresearch.com

Pharmacy Surveillance

Earning a score of 91.1, VigiLanz’s Dynamic PharmacoVigilance product acts as a bridge between a hospital’s pharmacy and lab information systems, automating the comparison of patients’ drug usage with lab results, then presenting the potential for adverse drug event reduction. Based on the system’s built-in rule sets or hospital-specific guidelines, it automatically generates warnings and alerts that help clinicians make appropriate drug therapy decisions.

“The product is extremely easy to use, and that has to be a big part of our success. Something that is hard to use or clunky wouldn’t work for our teams’ workflow. It doesn’t matter how good the quality of the material is; a clunky product wouldn’t work because we are moving at such a fast pace.

  • Manager, June 2020, klasresearch.com

In addition, VigiLanz’s Antimicrobial Stewardship product monitors antimicrobial therapy to ensure appropriate use, including unnecessary antibiotic therapy, de-escalation opportunities, positive rapid diagnostic test results, drug-bug mismatches, and opportunities for antibiotic “time-outs.” The Antimicrobial Stewardship dashboard shows usage and resistance trends across the organization, is Meaningful Use 3 certified, and is certified by the National Healthcare Safety Network for easy, direct reporting on antibiotic use.

“I have found VigiLanz to be really helpful with their ability to fine-tune a rule and screen out a lot of noise. So we are getting exactly what we need. We can tease out geography, look at specific organisms, or look at different time frames. This is very powerful and very easy to do in the system.”

  • Director, January 2020, klasresearch.com

“In what’s proven to be a particularly challenging year for our hospital customers, we’re extremely proud to continue our recognition by KLAS four years in a row,” said VigiLanz Chairman and CEO David Goldsteen, MD. “We know our customers rely on us when they need it most—whether that’s triaging COVID-19 cases, monitoring the use of specific pharmaceuticals during a shortage, or saving clinicians time providing real-time alerts and reports so they can focus more on patients. It’s our job to help hospitals keep patients safe, and we’re honored to see the glowing feedback from this past year.”

Best in KLAS is a recognition given to vendors for outstanding efforts to help healthcare professionals deliver better patient care. The Best in KLAS designation is reserved for the software and services market segments that have the broadest operational and clinical impact on healthcare organizations. Rankings are based on customer surveys of North American healthcare leaders, administrators, clinicians, and others who interact with the solutions.

Selected commentary collected about VigiLanz Infection Control and Monitoring and Pharmacy Surveillance, January 2021  © 2021 KLAS. Visit klasresearch.com for a complete view.

###

About KLAS

KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers and payers to be heard and counted. Working with thousands of healthcare professionals, KLAS gathers insights on software, services and medical equipment to deliver timely reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly represents the voice of healthcare professionals and acts as a catalyst for improving vendor performance. To learn more about KLAS and the insights we provide, visit www.KLASresearch.com.

About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care.

Freeman Medical Focus – KSN Fourstates News | VigiLanz

Freeman Health System, which is based in Joplin, Missouri and serves an area of 450,000 people across Missouri, Arkansas, Kansas, and Oklahoma, has been using VigiLanz since 2018 to enhance their antimicrobial stewardship processes. In an interview with KSN Fourstates Homepage, Adrienne Carey, Clinical Pharmacist, and Jessica Liberty, Freeman Infection Preventionist, discuss how VigiLanz is helping them automatically track important trends in drugs, dosage, and kidney function.

By Gretchen Bolander, KSN Fourstates Homepage

 

You can read the full article on KSN Fourstates Homepage.

 

 

Transcript:

Keeping an eye on every patient in the hospital is more than a full time job. But some digital help is making sure patients are getting the smallest effective dose and steering clear of infections.

Adrienne Carey, Clinical Pharmacist, said, “It’s a data mining software program that we use in the pharmacy, our inpatient pharmacy, and it looks at all our in patients in the hospital.”

It’s called Vigilanz and it keeps tracks of important trends in drugs, dosage, and kidney function.

“It brings all those stuff to our attention in real time, there’s rules we build to help us catch some of those scenarios that we want to know about so we can intervene in a timely fashion.”

Before Vigilanz, it was a manual process.

“We would run a report out of our health info system to get a list of patients that are on a list of drugs and after that we would go into each electronic medical record or paper chart and dig to find what is their kidney function, is this the right dose for them, is this the right antibiotic for them, have they been vaccinated?”

Vigilanz can play a role in a wide range of cases, including the pandemic.

Jessica Liberty, Freeman Infection Prev.,said, “Covid is one of our activations we have a rule built in for that.”

Preventing infection is another role that Vigilanz helps with.

“You can imagine — we have 250 – 300 patients every day.”

Gathering that information and flagging areas of potential concern, helping patients get better and get home.

 

Vigilanz Offers COVID-19 Vaccine Management Solution Free to Customers | Healthcare IT Today

VigiLanz, a clinical surveillance company, announced the launch of a new mass vaccination support software. The company is offering Vigilanz Vaccinate free to its existing customers to help frontline healthcare teams stay safe.

I had the chance to sit down with Stacy Pur, Vice President of Product Development at Vigilanz to find out more about their product and to talk through some of the unique challenges of these early vaccines.

Why Free?

“The COVID-19 issue is personal—at VigiLanz, we have had employees and family members contract COVID-19 and require medical intervention,” said David Goldsteen, VigiLanz’s CEO. “We are so grateful for the amazing care healthcare teams are delivering across the country, and we wanted to do something to help. It was important to us to offer this tool [Vigilanz Vaccinate] to current customers for free to help them and their frontline healthcare teams stay safe during this extremely challenging global pandemic. It’s the right thing to do.”

You can read more of this article on Healthcare IT Today.

VigiLanz Launches New Software for Hospitals to Rapidly Deploy and Manage COVID-19 Mass Vaccination Events for Healthcare Workers

VigiLanz Vaccinate helps hospitals manage their COVID-19 risk, reduce vaccine waste, and automate data collection for CDC and state reporting

MINNEAPOLIS – Dec. 16, 2020 – VigiLanz, a clinical surveillance company, today announced the launch of a new mass vaccination support software, built on its leading enterprise software platform. VigiLanz Vaccinate provides end-to-end management of the entire vaccination process, enabling hospitals to maximize the success of mass vaccination events for healthcare workers. Especially critical now, as hospitals seek to protect staff members and patients from COVID-19 transmission, VigiLanz Vaccinate can also be used to manage annual influenza vaccination and other events. Current customers are being given priority access to the software, at no cost.

“It’s critical for hospitals to rapidly roll out the COVID-19 vaccine to staff—not only to keep frontline healthcare workers safe, but also to protect their families and the patients they work with until the vaccine is available to everyone,” said Stacy Pur, VigiLanz’s VP of Product Development. “The COVID-19 vaccine presents some unique challenges for mass vaccination events, as it expires quickly once thawed and requires two doses spaced at specific intervals. VigiLanz Vaccinate was designed to help manage this process, ensuring the maximum number of staff receive the vaccine as efficiently as possible.”

VigiLanz Vaccinate streamlines vaccine administration and management by making it easy for staff to register and provide consent, while automating workflows for program administrators. Its real-time insights into volume needs reduce vaccine waste, while analytics give visibility into vaccination and immunity rates at the individual, department, hospital, and system-level. The software issues automated reminders to healthcare staff to register and attend appointments for both vaccine doses, and report any side effects. In addition, it collates data for critical reporting back to the Centers for Disease Control (CDC), Vaccine Adverse Event Reporting System (VAERS), and the state, for immunity rates and any adverse side effects.

“The COVID-19 issue is personal—at VigiLanz, we have had employees and family members contract COVID-19 and require medical intervention,” said David Goldsteen, VigiLanz’s CEO. “We are so grateful for the amazing care healthcare teams are delivering across the country, and we wanted to do something to help. We’re proud of this demonstration of innovation and agility from our product team. When the pandemic hit, we created COVID Quick Start, a software module to help hospitals quickly implement a COVID-19 infection prevention solution. Now, with VigiLanz Vaccinate, we’ve rapidly developed and deployed an offering that our team saw a critical need for—helping frontline healthcare workers get vaccinated against COVID-19 as quickly and efficiently as possible. It was important to us to offer this tool to current customers for free to help them and their frontline healthcare teams stay safe during this extremely challenging global pandemic. It’s the right thing to do.”

VigiLanz is prioritizing current customer implementations to ensure their needs are met, with plans to accept future-customer inquiries as early as January 2021. Please direct requests to vaccinate@vigilanzcorp.com, and learn more at Vigilanzcorp.com/vaccinate.

 

###

 

About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care.

 

Media Contact
Vanessa Ulrich
(410) 534.1161
vulrich@sage-growth.com

 

VigiLanz Announces Winners of 2020 Vigi Awards

Seven hospital systems are recognized for their outstanding commitments to patient safety and success in implementing clinical surveillance programs

 

MINNEAPOLIS – Nov. 18, 2020 – VigiLanz, a clinical surveillance company, today announced the winners of its annual Vigi Awards, which honor innovative hospitals around the country. This year, seven hospital systems are recognized for their exemplary patient safety achievements and their successful implementation of robust clinical surveillance programs.

VigiLanz’s annual Vigi Awards are designed to recognize how customers’ vigilance has contributed to healthier hospitals. VigiLanz customers have the opportunity to nominate individuals or teams who have gone above and beyond to drive optimal and innovative uses of VigiLanz to support patient care. Winners receive a donation to a charity of their choice. This year’s winners are:

Mount Sinai Beth Israel of the Mount Sinai Health System, New York, NY

Recognized for: Creating novel, new reports with VigiLanz leading to patient care improvements including a 75% decrease in the rate of catheter-associated urinary tract infections (CAUTIs) and a significant reduction in central line-associated bloodstream infection (CLABSIs), as well as significant cost savings and a faster infection prevention response to the first surge of COVID-19 patients in New York City.

EvergreenHealth, Kirkland, WA

Recognized for: Fully utilizing VigiLanz to make significant care improvements, including hospital-wide reductions in surgical site infections (SSIs) and standardized infection ratios (SIRs), reducing both by 75% over the last six months of 2019.

SCL Health, Broomfield, CO; SCL Health St. Vincent, Billings, MT

Recognized for:

  • Reducing the readmission rate of patients discharged from the emergency department with an infection through implementation of a new process, supported by VigiLanz, that enables pharmacists to quickly identify and reach out to discharged patients who might benefit from an alternate antibiotic
  • Faster identification of infections and precise enterprise-level monitoring, including the implementation of system-level healthcare-associated infection (HAI) dashboards that are instrumental to monitoring and comparing infection prevention performance across the full SCL enterprise

St. Bernards Medical Center, Jonesboro, AR

Recognized for: Innovative clinical surveillance initiatives that have had a widespread impact on patient care, including:

  • Decreasing the rate of vancomycin-induced acute kidney injury (AKI) from 10.34% to 4.79%
  • Decreasing broad spectrum gram-negative antibiotic days of therapy per 1000 patient days by 1%
  • Reducing the percentage of patients receiving more than 50 morphine milligram equivalents (MME) per day while admitted to the hospital by 3.27%

CHRISTUS Health Shreveport-Bossier, Shreveport, LA

Recognized for: Quickly implementing significant care improvements during the first year of VigiLanz use to achieve patient care and efficiency improvements, leading to more rapid identification of infections and enhanced compliance.

Health First Holmes Regional Medical Center, Melbourne, FL

Recognized for: New and innovative uses of VigiLanz that have brought significant benefits to patients, including:

  • Fewer incidences of hyperglycemia (62% vs 37%) in COPD patients
  • Fewer incidences of severe hypoglycemic events in patients with insulin (7% to 5%)
  • Optimized use of Kcentra

Northern Arizona Healthcare – Flagstaff Medical Center, Flagstaff, AZ

Recognized for: Using VigiLanz alerts to enhance care and manage drug supply shortages during the COVID-19 pandemic, including issuing alerts to relevant providers when:

  • Readmitted patients have a history of COVID-19
  • Key medications are ordered, such as Hydroxychloroquine and Remdesivir
  • Critical medications in short supply are ordered

 

“We were among the first and hardest hit hospitals by COVID-19,” said Kristen Bamberg, Lead Critical Care Pharmacist, Northern Arizona Healthcare. “We worked with VigiLanz to be forward thinking about how to tackle this challenge while supporting our pharmacists, providers, nurses, and patients. This enabled us to be nimble enough to work through countless therapeutic and workflow issues in real time. It’s an honor to be recognized by VigiLanz for our dedication to improving patient care.”

“We are incredibly proud of these hospital organizations for their achievements,” said Erik Johnson, VigiLanz’s Chief Commercial Officer. “Their improvements in patient safety, outcomes, and cost savings are exactly why we exist as an organization. We’re thrilled to recognize this year’s Vigi Award winners and inspire others through their success. To the winners – thank you for allowing VigiLanz to be part of your success.”

Learn more about this year’s Vigi Award winners here.

 

###

 

About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care.

 

Media Contact

Vanessa Ulrich

(410) 534.1161

vulrich@sage-growth.com

Why most hospitals could save millions by improving patient safety

by Erik Johnson, VigiLanz CCO

Improving patient safety and increasing the bottom line aren’t competing priorities. Here’s how hospitals can accomplish both objectives.

The first wave of Covid-19 may gave subsided in some areas of the country, but in others it is growing and hospitals everywhere are continuing to face significant challenges.

The American Hospital Association recently estimated that hospitals will incur at least $323.1 billion in losses through the end of this year due to Covid-19. Key contributors include postponed and canceled elective procedures, lower patient volumes across all departments, and higher costs for supplies and devices.

Other factors compound the financial challenges, including pressure for hospitals to implement new initiatives that foster a safer care environment for Covid-19 patients, non-Covid-19 patients, and healthcare providers. This pressure is mounting, as spikes in cases continue to appear in various regions, and as concerns grow about the flu season.

You can read more of this article on MedCityNews.  

Hospital Patient Safety Report: Infection Prevention Findings

To better understand the state of hospital patient safety and the biggest opportunities for improvement, VigiLanz commissioned Sage Growth Partners, a healthcare consultancy, to conduct an independent survey of 100 hospital and health system leaders in February 2020.

View the full report here.

This infographic highlights some of the most noteworthy infection prevention-related survey findings. The infographic reveals:

  • How hospital leaders rate their infection prevention efforts
  • Where infection prevention falls on their list of top safety priorities
  • How they are using technology to support their efforts

Podcast: Top Patient Safety Considerations for Hospitals as Flu Season Approaches

Tips for Health Systems

Stacy Pur, Vice President of Product Development at VigiLanz, shares her unique perspective on the challenges facing hospital systems as a result of the pandemic, including the impact on ICU nurses and hospital staff. In this conversation with Integrated Healthcare Executive, she shares how hospitals can increase patient safety, curb infection rates, and address flu season as it begins.